Axq Capital, LP Haleon PLC Transaction History

Axq Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$8.02 - $8.67 $121,904 - $131,784	-15,200 Reduced 16.05%	79,500 $675 Million
Q4 2023 Feb 13, 2024	BUY	$7.78 - $8.62 $736,766 - $816,313	94,700 New	94,700 $779 Million
Q1 2023 May 10, 2023	BUY	$7.57 - $8.37 $315,199 - $348,510	41,638 Added 408.22%	51,838 $422 Million
Q4 2022 Feb 10, 2023	BUY	$5.96 - $8.06 $60,792 - $82,212	10,200 New	10,200 $81.6 Million

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.